Asthma market to remain stable over next decade, despite generic erosion – The Pharma Letter


The Pharma Letter

Asthma market to remain stable over next decade, despite generic erosion
The Pharma Letter
New market potential in underserved asthma population: Emerging anticytokines that are predicted to launch during the next decade will serve part of the unmet need in the severe, refractory asthma population, which is currently served by only systemic …

View full post on asthma – Google News

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.